Two Sigma Securities, LLC Alkermes Plc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$26.4 - $32.56 $207,900 - $256,410
7,875 New
7,875 $213,000
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $551,061 - $648,415
20,282 Added 104.06%
39,773 $1.11 Million
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $552,374 - $655,482
19,491 New
19,491 $610,000
Q1 2018

May 15, 2018
BUY
$53.61 - $67.26 $580,649 - $728,493
10,831 New
10,831 $628,000

Others Institutions Holding ALKS

# of Institutions
361
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email